Vertical concerns dog CVS/Aetna clearance

The Department of Justice’s approval of CVS Health’s $69 billion acquisition of health insurer Aetna with only the divestiture of a horizontally overlapping business has left many observers still worried about the deal’s competitive effects.

Get unlimited access to all Global Competition Review content